Integral membrane proteins in eukaryotes are central to various cellular processes and key targets in structural biology, biotechnology and drug development. However, the number of available structures for eukaryotic membrane protein belies their physiological importance. Recently, the number of available eukaryotic membrane protein structures has been steadily increasing due to the development of novel strategies in construct design, expression and structure determination. Here, we examine the major expression systems exploited for eukaryotic membrane proteins. Additionally we strive to tabulate and describe the recent expression strategies in eukaryotic membrane protein structural biology. We find that a majority of targets have been expressed in advanced host systems and modified from their wild-type form with distinct focus on conformation and thermo-stabilisation. However, strategies for native protein purification should also be considered where possible, particularily in light of the recent advances in single particle cryo electron microscopy.
Introduction
Integral membrane proteins (IMPs) undertake a myriad of cellular functions, which range from sensory stimuli transduction and catalysis to transport and energy transduction. IMPs account for approximately 30% of all protein-coding genes in humans and are important targets for pharmaceuticals and drug development. The structures obtained to date reflect only a tiny fraction and generally represent the most tractable targets, i.e., those expressed to high abundance either natively or through recombinant systems. However, the rate by which new structures of IMPs and in particular eukaryotic integral membrane proteins (eIMP) emerge is steadily increasing due in no small part to innovative protein expression, engineering and structure determination strategies developed over the last few years [1] .
In this review, we compare and contrast the various expression systems available for eIMPs with a focus on the last two years (Supplementary Table 1 ). We extract recent advances and summarise the general principles emerging in the field of eIMP structural biology.
Expressions systems
Early structures of eukaryotic membrane proteins exploited the natural abundance of selected targets. Native sources remain a significant source of structural information (Supplementary Table 1 , Figure 1a) , and likely will remain so also in the future with the recent rise of single particle cryo-electron microscopy (cryo-EM) as typified by the structures of the inositol-1,4,5-trisphosphate (IP3) receptor [2] , the ryanodine receptor [3, 4] and the voltage-gated calcium channel Cav1.1 complex [5] . For the latter two, the respective native proteins were purified by a pull-down purification approach using a recombinant GST-fused accessory protein [4, 5] . CRISPR technology may also be helpful to introduce affinity tags or proteolytic sites into target proteins in a native background.
The majority of eIMPs however are expressed at very low levels in native sources, so recombinant over-expression is required for structural and functional characterisation. The choice of an expression system for an eIMP target is generally dictated by 1) the locally accessible expression systems, where already present knowledge and experience can significantly improve productivity, 2) the nature and complexity of the chosen target, and 3) cost. Typically, the expression of a range of homologs representing a variety of species are screened for the best and most stable expressing proteins, although for drug development a close homology to the pharmacological target will be required. Indeed, for bacterial to mammalian expression systems, high-throughput pipelines exist for the evaluation of GFP fusion constructs based on expression and sample homogeneity using fluorescence size exclusion chromatography as reviewed elsewhere [6] [7] [8] [9] [10] [11] .
Bacteria
The most common bacterial expression system, Escherichia coli (E. coli) is a rapid, versatile and cost effective expression system. The system has limitations due to different protein folding chaperones and a lack of essential lipids and posttranslational modifications (PTMs) required for proper eIMP expression. Despite the many attempts to improve the expression of active eIMPs in E. coli including coexpression of molecular chaperones, tagging the target protein with a fusion protein and co-expression of post-translational machineries [12] , E. coli remains a challenged system for the over-expression of eIMPs (Supplementary Table 1, Figure 1 ). Indeed, of the 11 eIMP structures derived from E. coli expression (Supplementary Table 1) , over half were either fragments or required refolding.
Yeasts
Yeast was the first successful system for recombinant expression of eIMPs for crystallographic studies [13, 14] . The most common yeast strains for the overexpression of eIMPs for structural studies are Saccharomyces cerevisiae (S. cerevisiae) [7, 8, 14] and the methylotrophic Pichia Pastoris (P. pastoris) [6, [15] [16] [17] (Supplementary Table 1 ). Both strains are cost effective eukaryotic expression systems capable of performing various PTMs including high mannose Nglycosylation. However, the absence of specific sterols might be one of the reasons that only a limited number of eIMP structures have been obtained using yeast expression systems (Figure 1b and c, Supplementary Table 1) .
Expression in P. pastoris uses an integrated vector compared to the multicopy plasmid system in S. cerevisiae. The most common vector used in P. pastoris expression system, pPICZ, uses a promoter derived from the alcohol oxidase I (AOXI) gene, which is inducible by methanol and carries a simple drug-based selection system (Zeocin). Most vectors used in S. cerevisiae expression systems are propagated using the high copy 2-micron plasmid replication origin [18] . Recently, taking advantage of incorporating a defective leu2-d gene, in addition to the primary selection marker, has promoted an even higher plasmid copy number under leucine deficient growth conditions leading to improved expression levels [19] [20] [21] . Expression in S. cerevisiae mostly utilizes GAL1, a strong inducible promoter, which drives expression of the target gene following depletion of glucose and addition of galactose as the carbon source during culturing.
Insect cell
Baculovirus transduction of insect cells is the dominant heterologous expression system for the production of eIMPs, especially mammalian/human targets that have yielded structures over the past two years including a surge of G-protein coupled receptors ( Figure 1 ). The gene of interest is cloned into the pFastBac vector, which controls the expression of the target gene by either the strong Autographa californica multiple nuclear polyhedrosis virus (AcMNPV) polyhedrin (PH) or p10 promoters. The vector is then used to produce a recombinant baculovirus shuttle vector (bacmid) [22] to transfect the insect cells for expression of the target protein [23] . This can be further adapted for the expression of multi-gene complexes using the Multibac system as reviewed in [24] [25] [26] . The two most common insect cell lines are Spodoptera frugiperda (sf9 and sf21) and Trichoplusia ni (Hi5). The majority of eIMPs structures are obtained from the S. frugiperda expression system ( Figure 1 ).
Lipid content, PTMs and protein folding in insect cells more closely resemble mammalian than bacterial and yeast systems. However, N-glycosylation in insect cells results in simple oligo-mannose sugar chains, while mammalian cells produce more complex N-glycans containing terminal sialic acids, which is a limitation as Nglycans often contribute to the functionality of the glycoprotein [27] . Engineered insect cell lines that express the enzymes required for mammalian-like glycosylation patterns can produce complex terminally sialylated N-glycans if required [28] [29] [30] .
Mammalian cell
The need for specific PTMs and a near-native-like lipid environment for some mammalian membrane proteins make the use of mammalian cell expression systems highly desirable [1] . The human embryo kidney (HEK) and Chinese hamster ovary (CHO) are the two most common mammalian cell lines for recombinant expression of membrane proteins. While both cell lines can be subjected to transient and stable transfections [31] , transient transfection of HEK293SGnTI− (N-acetylglucosaminyltransferase I-negative) is responsible for the majority of eIMPs whose structures are deposited in PDB over the past two years (Supplementary Table 1 ). Despite the slow growth rate and traditionally higher cost of mammalian expression systems [32] , the number of structures generated based on such systems has considerably increased ( Figure 1 ) [1, 33] . Recently, Lin et al reported increased GFP and AMPA receptor expression under mild hypothermia conditions [34] . With recent increases in cryoEM studies it is also foreseeable that mammalian cell expression will increase since considerably less material is required compared to crystallographic studies.
Baculovirus mediated gene transduction of mammalian cells (BacMam) has been widely used due to its compatibility with a variety of mammalian cell lines, the possibility of co-infecting with multiple BacMam viruses to express protein complexes and its rapid and efficient target over expression [9, 35] . Furthermore, recent modifications of the BacMam system allow for assembly of multiple expression cassettes and, by taking advantage of having GFP fusion constructs of the target proteins, high throughput screening of constructs by small-scale transfection/FSEC before moving to large-scale protein expression [9] .
Cell free
Cell-free protein expression is a rapid method for synthesis of recombinant proteins that uses cell lysates as the source of the whole protein translational machinery. The cell lysate can be derived from a variety of sources ranging in complexity from bacterial to mammalian systems each attempting native lipidation, glycosylation, phosphorylation and other PTMs [36] . Providing modifying enzymes can in principle make PTMs possible even in E. coli, however the quality and homogeneity of PTMs is unlikely to be sufficient for downstream structural studies [37] .
Pre-expression strategies
The screening of a range of orthologues should be carried out to identify a promising starting target. However, this alone is normally not enough to lead to a structure, and additional testing and modification needed. In the last two years only ~12% of recombinant eIMP structures were solved with the native full-length sequence (Supplementary Table 1 and Supplementary Figure 3) . In recent years the trend has been to modify the protein construct before structural studies. Such modifications can be classified broadly as pre-expression and post-expression, and will be described in the coming sections.
Pre-expression modifications comprise a range of strategies that directly alter the gene of interest in an effort to improve the conformational/thermo-stability and/or "crystallizability" of the expressed protein. These strategies include the addition of point mutations to 1) improve protein stability 2) remove post-translational modification sites and 3) alter the surface properties of the protein, as well, as the truncation of disordered termini and loops or their substitution by ordered fusion proteins such as T4 lysozyme (T4L) and cytochrome b 562 RIL (BRIL) [38, 39] .
Construct design for structural studies
Conformational/Thermo stabilisation Thermostabilisation involves the systematic screening of point mutations (typically alanine) that translate to an increase in the protein 'melting temperature' as determined by a radioligand binding or a fluorescent thermostability assay. These mutations often render the protein inactive or locked in a discrete conformation, and therefore an assay based on a proper enzymatic activity may not be amenable. In the last two years, ~14% of the eIMP structures determined have involved the inclusion of thermostabilising mutations (Supplementary Table 1 and Supplementary Figure 3) . However, the process to identify thermostabilising mutations can be quite cumbersome especially for larger proteins. Experimentally, this can be partly overcome by either limiting mutational space [40, 41] or through the use of highthroughput methods [42] [43] [44] . Alternatively, in silico stability calculations and sequence conservation may offer some guidance [45] but often require a priori knowledge, which obviously is not available to novel, unknown structures. Recently, Sauer et al. reported two different multiple sequence analysis methodologies to identify potentially thermostabilising mutations, centred on a rationalisation of a correlation between an organism's optimum growth temperature and protein stability [46] . These results lend hope that rational strategies can be devised to facilitate the process.
Protein engineering
Another common strategy to generate a stable target for structural studies is the truncation of the termini and loop regions, focussing on disordered regions that can potentially affect crystal packing or promote protein aggregation (Supplementary  Table 1 and Supplementary Figure 3) . Useful sites for truncation can be identified experimentally through limited proteolysis, or in silico [47] using sequence alignments and a number of online tools, which serve to either predict regions of conserved special features (secondary structure, transmembrane topology [48] and domains [49] ) or disordered regions within protein sequences [50, 51] .
An alternative to the truncation of a disordered protein region is to replace it with a suitable fusion protein. Solutions currently in fashion include the stabilised BRIL and T4L moieties, which in the GPCR field are used to typically replace intracellular loop 3 of the receptor [38, 39] . In addition to an overall stabilising effect on the protein these fusions can also play a role in the formation of crystal contacts. Recently, Yin et al. introduced a novel fusion protein in the structure determination of the human OX2 receptor, namely the catalytic domain of the Pyrococcus abysii glycogen synthase [52] . The generation of chimeras from domains of related proteins represents an alternative approach to thermostabilisation and can provide a unique source for crystal contacts [53] [54] [55] [56] .
Webservers can also be used to predict a range of PTM sites, for mutagenesis [57] . In addition, webservers also allow for the identification of residues for mutation to lower the surface entropy of the target protein promoting more favourable interactions for crystallisation [58] .
Purification tags
For many, the workhorse poly-histidine tag remains the purification strategy of choice for eIMPs irrespective of expression system (Figure 2a ). However, in the case of the higher eukaryote expression systems, such as HEK cells, the use of the more specific cobalt charged IMAC resin is often preferred over traditional nickel-NTA resin, due in part to the expanded range of sequences that can bind Ni-NTA. Alternatively, protein affinity tags (StrepII) or antibody affinity tags (FLAG and 1D4) offer an additional advantage of increased specificity and remain an attractive option for instances of low expression.
Post-expression strategies
Post-expression strategies cover a range of approaches that can be applied to the protein of interest before and during purification. They include the use of small molecules (ligand, inhibitors, lipids) or proteins (nanobodies, antibodies) to stabilise the target protein in a given conformation and represent a common strategy for receptors and transporters [59] . The add-back of native and non-native lipids during purification serves to offset the delipidation of the protein target during subsequent chromatography, thus increasing stability. In addition, surface modification of the protein by alkylation of free cysteines or the reductive methylation of lysine can also be exploited to modify the solution properties of the target.
Enzymatic treatment of the protein to remove PTMs or disordered regions (limited proteolysis) can be employed to generate a more homogenous protein sample [59] .
These enzymatic approaches would be advisable if mutation of PTM sites or truncation of disordered regions lead to lower expression levels than that of the mature full-length protein. The efficiency of limited proteolysis can be improved by the introduction of a specific protease site in the region of interest [60] .
Detergents
The choice of detergent is central to the success of structural and functional studies of IMPs [61] . However, choosing a detergent is largely empirical, which can be further complicated as the optimal solubilisation detergent is often not compatible with structure determination. GFP-fusion constructs offer a high-throughput tool amenable for the rapid screening of detergents at various stages of the solubilisation and purification pipeline [8, 42] . Recently, methods for the characterisation of protein detergent complexes have been reported centred on multiple detections during size exclusion chromatography [62, 63] .
Dodecyl-B-D-maltoside (DDM) and a combination of DDM and cholesteryl hemisuccinate (CHS) represent the solubilisation detergent compositions of choice for ~45% of the structures solved in the past two years, dropping to 30% for the purification/structure solution detergent compositions (Figure 3a and b, Supplementary Table 1 ). In the case of the latter, the detergent choice tends towards those with low critical micelle concentrations or smaller micelles (Figure 3b , Supplementary Table 1) .
Alternative approaches to protein reconstitution have been described including saposin lipoprotein nanoparticles and styrene maleic acid co-polymer lipid particles (SMALPs) that have the potential to provide a detergent free approach in IMP structure determination, especially by cryo-EM [64] [65] [66] [67] .
Crystallisation
X-ray diffraction remains the most dominant method for eIMP structure determination over the past 2 years (Figure 3b ). Detergent-based methods are still the dominant approach for the crystallization of eIMPs (Figure 3c ). The purified detergentsolubilized protein is used directly in crystallization trials using conventional vapor diffusion, dialysis and microbatch methods. However, detergents do not mimic the native lipid bilayer and can cover most of the protein surface area available for crystal contacts [68] . While the latter can be offset using shorter chained detergents, these often destabilise the protein of interest [69] , not least eIMPs.
Addition and control of lipids can play a key role in improving crystal packing. The protein sample can be re-lipidated throughout purification and crystallization to obtain crystals such as for the Drosophila melanogaster dopamine transporter that was relipidated prior to crystallization [70] , or by using the high-lipid high-detergent approach (HiLiDe) [71] [72] [73] [74] . The HiLiDe method, inspired by detergent solubilization of enriched microsomes from native sources (e.g., pig kidney Na,K-ATPase and rabbit fast-twitch muscle SERCA1a, Figure 3c and Supplementary Table 1) , utilizes overnight mixing of extra lipid and/or detergent with the purified protein sample [75, 76] . A mild lipid exchange can be obtained by ultracentrifugation in sucrose gradients, where specific lipid/cholesterol compositions can be obtained without going through de-lipidating steps or demanding chromatography in lipidated buffers [76] .
Another lipid based crystallisation method is the lipidic cubic phase (LCP) method [77] , which has been essential for the structure determination of GPCRs [78] including the engineered rhodopsin-arrestin complex [79] , and also non-GPCRs such as the human glucose transporter GLUT3 [80] the vacuolar H + /Ca 2+ exchanger (VCX1) [81] and prostaglandin E2 synthase [56] (Supplementary Table 1, Figure 3c ).
The third lipid-based crystallization method is the bicelle method [82, 83] . Bicelles are membrane mimetic systems comprising of lipid bilayer disks that are formed in certain lipid/amphiphile mixtures, and shares characteristics with LCP and HILIDE. Recently, the structure of voltage dependent anion channel 1 (VDAC1) has been determined from bicelle grown crystals [84] .
Conclusions and perspectives
The structural studies of eIMPs is a largely empirical process. While some degrees of bias exist in the data presented here, i.e. GPCRs represent 22% of the entries, clear trends in the choice of expression system and the design of constructs are noted from the analysis of successes over the past two years. This involves the screening of a range of orthologues in the chosen expression system, with the caveat that success for mammalian genes is more probable when using a more complex expression system. For crystal based structural studies, pre-and post-expression modification of the target increases the chances of success. This can be hallmarked by the revolution in GPCR structural biology that has been driven in large by the establishment of a number of pipelines that combine many pre-and post expression strategies required for success. Expression modifications may on the other hand be less critical for cryoEM. These strategies will be critical for success in the future studies of the many eIMPs that remain of unknown structure and function, and the higher-order complexes in biomembranes. 1 1 1 1 1 1 1 1 1 1 1 1 1 1   1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 Suppl. Figure 3 Supplementary NMDA receptor (GluN1/GluN2B heterodimer) bound to GluN2B specific allosteric modulator, GluN1 and GluN2B partial agonists and ion channel blocker
Counts

N a t i v e E s c h e r i c h i a c o l i E s c h e r i c h i a c o l i -C e l l F r e e P i c h i a p a s t o r i s S a c c h a r o m y c e s c e r e v i s i a e S p o d o p t e r a f r u g i p e r d a T r i c h o p l u s i
T r u n c a t i o n T r u n c a t i o n + f u s i o n T r u n c a t i o n + f u s i o n + t h e r m o s t a b i l i s a t i o n L i m i t e d p r o t e o l y s i s T r u n c a t i o n + f u s i o n + d e g l y c o s y l a t i o n T r u n c a t i o n + d e g l y c o s y l a t i o n T r u n c a t i o n + d e g l y c o s y l a t i o n + s t a b i l i s a t i o n T r u n c a t i o n + t h e r m o s t a b i l i s a t i o n T r u n c a t i o n t o T M T r u n c a t i o n a n d r e m o v a l o f l i p i d s i t e T r u n c a t i o n + C h i m e r a F u s i o n + t h e r m o s t a b i l i s a t i o n F u s i o n D e g l y c o s y l a t i o n T r u n c a t i o n + t h e r m o s t a b i l i s a t i o n + d i r e c t e d e v o l u t i o n T r u n c a t i o n + t h e r m o s t a b i l i s a t i o n + d e g l y c o s y l a t i o n T r u n c a t i o
t i o n s t a b i l i s a t i o n M u t a t i o n L o o p t r u n c a t i o n L i m i t e d p r o t e o l y s i s + d e g l y c o s y l a t i o n + c o n f o r m a t i o n s t a b i l i s a t i o n L i m i t e d p r o t e o l y s i s + c o n f o r m a t i o n s t a b i l i s a t i o n
M. musculus H. sapiens T--REx--
X. laevis/ HEK293S GnTI−
Replacement of C--terminus with 11 residues from GluA2, mutations to remove reactive cysteines and glycosylation sites, reduce surface entropy, and improve thermostability, conformational homogeneity and expression levels 
sapiens), Bos taurus (b. taurus), Rattus norvegicus (R. rattus), Mus musculus (M. musculus), Danio rerio (D. rerio), Xenopus laevis (X. laevis), Oryctolagus cuniculus (O. cuniculus), Gallus gallus (G. gallus), Drosophila melanogaster (D. melanogaster), Saccharomyces cerevisiae (S. cerevisiae), Cyanidioschyzon merolae (C. merolae), Sus scrofa (S. scrofa), Squalus acanthias (S. acanthias), Triticum aestivum (T. aestivum), Oryza sativa (O. sativa), Nectria haematococca (N. haematococca), Actinia fragacea (A. fragacea), Ascaris suum (A. suum), Arabidopsis thaliana (A. thaliana), Spinacia oleracea (S. oleracea), Pisum sativum (P. sativum), Chlamydomonas reinhardtii (C. reinhardtii), Ciona intestinalis (C. intestinalis), Yarrowia lipolytica (Y. lipolytica), Pichia pastoris (P. pastoris), Escherichia coli (E. coli), Spodoptera frugiperda (S. frugiperda), Trichoplusia ni (T. ni).
